目的 探讨伴骶骨广泛破坏的黏液乳头型室管膜瘤的临床病理学特点、诊断及鉴别诊断。方法 对1例骶骨广泛性破坏黏液乳头型室管膜瘤的临床和影像学资料、病理学特征及免疫表型进行观察分析。结果 患者,女性,73岁,腰骶部疼痛不适1个月,不慎摔伤腰骶部入院,骶尾椎MRI示骶2-3椎体肿瘤,考虑恶性。组织学形态示肿瘤细胞呈立方或长梭形放射状排列在血管间质轴心周围,形成乳头状结构,乳头缺乏的区域,常见黏液形成微囊,并将肿瘤细胞和玻璃样变的血管轴心隔开,肿瘤细胞无多形性,核分裂像少见。免疫组化结果:GFAP(+),S100(+),Vimentin(+),EMA(－),CKpan(－),Ki67(＜1%阳性)。结论 伴骶骨广泛溶骨性破坏的黏液乳头型室管膜瘤少见,具有惰性生物学行为,生长缓慢,切除不净可复发,特别需要与发生在骶骨的脊索瘤和转移性癌相鉴别。
Objective To investigate the clinical and pathological features, diagnosis, and differential diagnosis of myxopapillary ependymoma (MPE) with extensive sacral destruction.Methods Retrospective analysis of the clinical and radiological data, histopathological morphology, and immunophenotype was conducted for one case of MPE with extensive sacral destruction.Results The patient, female, 73 years of age, with a history of low backache for one month, was admitted to hospital with lumbosacral injury.MRI image demonstrated lesions involving vertebral bodies of S2-3.Microscopically, the lesion was composed of cuboidal to elongated tumour cells radially arranged in a papillary manner around vascularied stromal cores.In areas without nipples, myxoid matrix material accumulated between tumour cells and hyaline blood vessels.The tumour cells showed no pleomorphism, with low mitotic activity.Immunohistochemically, tumour cells were positive for GFAP, S100, and Vimentin, and negative for EMA and cytokeratin.Ki67 labeling index was <1% positive.Conclusion MPE with extensive sacral destruction is a rare tumor with indolent behaviour.Late recurrence may occur with incomplete resection.Differential diagnosis include chordoma and metastatic carcinoma.
[1] Kurt E, Zheng P P, Hop W C J, et al.Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas[J].Cancer, 2006,106(2):388-395.
[2] Zaidi SN, Alkhalidi H, Al-Rikabi AC.Myxopapillary epen-dymoma masquerading as subcutaneous saccroccygeal non-healing ulcer: case report[J].Ann Saudi Med, 2014,34(3):262-264.
[3] Hayashi T, Haba R, Kushida Y, et al.Cytopathologic charac-teristics and differential diagnostic considerations of osteolytic myxopapillary ependymoma[J].Diagn Cytopathol, 2014,42(9):778-783.
[4] Shelekhova KV, Egorenkov VV, Kheinstein VA, et al.Myxopapillary ependymoma of lumbar soft tissue: a case reportwith gene expression evaluation[J].Int J of Surg Pathol, 2018,26(4):364-369.
[5] Beschorner R, Wehrmann M, Ernemann U, et al.Extradural ependymal tumor with myxopapillary and ependymoblastic differentiation in a case of Schinzel–Giedion syndrome[J].Acta Neuropathol, 2007,113(3):339-346.
[6] 冷冬妮,王海,石群立.黏液乳头型室管膜瘤临床病理研究进展[J].肿瘤防治研究, 2009,36(6):537-539.
[7] Rousseau A, Idbaih A, Ducray F, et al.Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade[J].J Neurooncol, 2010,97(3):353-364.
[8] Akyurek S, Chang E L, Yu T K, et al.Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D.Anderson Cancer Center[J].J Neurooncol, 2006,80(2):177-183.
[9] Rosai J.Rosai & Ackerman外科病理学:下卷[M].郑杰译.10版.北京:北京大学医学出版社, 2014:2358-2359.
[10] Cimino PJ, Agarwal A, Dehner LP.Myxopapillary ependymoma in children: a study of 11 cases and a comparison with the adultexperience[J].Pediatr Blood Cancer, 2014,61(11):1969-1971.
[11] Cihangiroglu M, Hartker FW, Lee M, et al.Intraosseous sacral myxopapillary ependymoma and the differential diagnosis of sacraltumors[J].J Neuroimaging, 2001,11(3):330-332.
[12] Ruchika G, Arvind R, Vaishali S, et al.Sacral myxopapillary ependymoma with extensive osteolysis[J].J Neurooncol, 2008,86(3):349-352.
